Literature DB >> 25952729

Relaxation effect of a novel Danshensu/tetramethylpyrazine derivative on rat mesenteric arteries.

Rachel Wai-Sum Li1, C Yang2, Luchen Shan3, Zaijun Zhang3, Yuqiang Wang3, Y W Kwan4, Simon M Y Lee5, Maggie P M Hoi5, S W Chan6, Alex Chun Cheung1, K H Cheung7, George P H Leung8.   

Abstract

Danshen (Radix Salviae miltiorrhizae) and ChuanXiong (Ligusticum wallichii) are two traditional herbal medicines commonly used in China for the treatment of cardiovascular diseases. The active components in Danshen and ChuanXiong are Danshensu (DSS, (R)-3, 4-dihydroxyphenyllactic acid) and tetramethylpyrazine (TMP), respectively. In the present study, a new compound named ADTM, which is a conjugation of DSS and TMP, was synthesized and its effect on the contractility of rat mesenteric arteries was examined. The relaxation effect of ADTM on rat mesenteric arteries was studied using myography. The effects of ADTM on Ca(2+) channels were measured by Ca(2+) imaging and patch-clamp techniques. The results showed that ADTM caused a concentration-dependent relaxation of rat mesenteric arteries. This relaxation effect was not affected by the removal of endothelium or inhibitors of nitric oxide synthase, cyclooxygenase, guanylyl cyclase and adenylyl cyclase. Potassium channel blockers including tetraethylammonium, iberiotoxin, apamin, 4-aminopyridine, BaCl2 and glibenclamide also failed to inhibit the relaxation response to ADTM. ADTM inhibited CaCl2-induced contractions and reduced the Ca(2+) influx in isolated mesenteric arterial muscle cells. Our results suggest that ADTM may be a novel relaxing agent. Its mechanism of action involves the direct blockade of voltage-gated Ca(2+) channels in vascular smooth muscle cells, resulting in a decrease in Ca(2+) influx into the cells.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium channel; Danshensu tetramethylpyrazine; Mesenteric artery; Relaxation

Mesh:

Substances:

Year:  2015        PMID: 25952729     DOI: 10.1016/j.ejphar.2015.04.041

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Enhancement of brain-targeting delivery of danshensu in rat through conjugation with pyrazine moiety to form danshensu-pyrazine ester.

Authors:  Ailing Hui; Huayang Yin; Zheng Zhang; An Zhou; Jingchao Chen; Li Yang; Zeyu Wu; Wencheng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II.

Authors:  Liang Wang; Xiaojing Zhang; Guozhen Cui; Judy Yuet-Wa Chan; Li Wang; Chuwen Li; Luchen Shan; Changjiang Xu; Qingwen Zhang; Yuqiang Wang; Lijun Di; Simon Ming-Yuen Lee
Journal:  Oncotarget       Date:  2016-05-31

3.  Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis.

Authors:  Qiaowen Li; Chih-Yang Huang; Shih-Ping Liu; Marthandam Asokan Shibu; Fuu-Jen Tsai; Yuan-Man Hsu; Chang-Hai Tsai; Jing-Gung Chung; Jai-Sing Yang; Chih-Hsin Tang; Shulin Wang
Journal:  Nutr Metab (Lond)       Date:  2020-01-31       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.